Ochre Bio
RNA medicines for liver diseases
Biotech
Genomics
About
Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.
Build your own investing agent
GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.
Join the GPAgent waitlistFounders (1)
Quin Wills
Founder/CSO
Details
Status
Active
Stage
Growth
Team Size
50
Regions
United Kingdom, Europe, Remote, Partly Remote